1.
Mid-term real world outcomes of the Hydrus ® Microstent in open angle glaucoma.
Kiramira David, Voßmerbäumer Urs, Pfeiffer Norbert, Linnerth-Braun Lea K M, Lorenz Katrin, Prokosch Verena
Eye (Lond)Jan 20243 citationsCase Series
This study found the Hydrus Microstent safely and effectively lowered IOP and medication dependence in open-angle glaucoma patients mid-term, offering a viable treatment option with some limitations.